Metraipolis › archive › dc_47b59aa67ce8

Repurposing Heart Failure Therapies in Pulmonary Arterial Hypertension: Mechanistic Rationale, Translational Evidence, and Clinical Perspectives for SGLT2… — Europe PMC PMID:42512887

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42512887
DOI
10.3390/medicina62071345
License (as archived)
solo-consultazione
Archived
2026-10-18T07:58:47.465Z
SHA-256 of the archived text
13499010ff242879f673a22ca3efd7d9f1ee7fe0dab346ff09c1601afa0e839f
Stable URL of this page
https://metraipolis.com/documento/dc_47b59aa67ce8

How to cite

Repurposing Heart Failure Therapies in Pulmonary Arterial Hypertension: Mechanistic Rationale, Translational Evidence, and Clinical Perspectives for SGLT2… — Europe PMC PMID:42512887 — Europe PMC (en), https://europepmc.org/article/MED/42512887 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_47b59aa67ce8 (Metraipolis archive dc_47b59aa67ce8, sha256 13499010ff242879f673a22ca3efd7d9f1ee7fe0dab346ff09c1601afa0e839f)
BibTeX
@misc{dc47b59aa67ce8,
  title = {Repurposing Heart Failure Therapies in Pulmonary Arterial Hypertension: Mechanistic Rationale, Translational Evidence, and Clinical Perspectives for SGLT2… — Europe PMC PMID:42512887},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42512887},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_47b59aa67ce8; sha256 13499010ff242879f673a22ca3efd7d9f1ee7fe0dab346ff09c1601afa0e839f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42512887. Agents can read the archived copy with the MCP tool read_document.